期刊文献+

牙髓卟啉单胞菌诱导成骨细胞表达RANKL mRNA的研究 被引量:2

RANKL mRNA expression induced by Porphyromonas endodontalis in rat osteoblasts
下载PDF
导出
摘要 目的研究牙髓卟啉单胞菌(porphyromonasendodontalis,Pe)ATCC35406对成骨细胞表达细胞核因子kappaB受体活化因子配基(receptoractivatorofnuclearfactor-kappaBligand,RANKL)的影响,探讨该菌诱导牙槽骨吸收的病理机制。方法采用原代培养的大鼠头盖骨细胞,分别以107、109CFU/ml的Pe感染细胞24h,为了观察细菌毒性作用的动力学变化,以107CFU/ml的Pe作用细胞0、6、12、18及24h,逆转录-聚合酶链式反应(RT-PCR)方法检测RANKLmRNA的表达。结果以107和109CFU/mlPe作用成骨细胞24h后,细胞表达RANKLmRNA与βactin的mRNA灰度值的比值分别为1.73、2.44。大鼠头盖骨细胞基础表达RANKLmRNA为0.32。以107CFU/mlPe感染细胞,随着感染时间的增加,细胞RANKLmRNA表达逐渐增强为0.93、2.01、1.97、1.73。结论Pe通过刺激成骨细胞RANKL的表达,激活OPG/RANKL/RANK(骨保护因子osterprotegerinOPG,细胞核因子kB受体活化因子receptoractivatorofnuclearfactor-kappaB,RANK)传导系统,能够诱导牙槽骨吸收,并且其作用具有密度依赖性和时间依赖性。 Objective:To study the effects of re(:eptor activator of nuclear factor -kB ligand -RANKL in osteoblasts (OBs) activiated by Porphyromonas endodontalis(Pe) ,and to investigate the bone resorptive pathogenesis induced by Pe. Methods: Primary rat calvarial osteoblasts were cultured, then were infected with Pe ATCC 35406 at the density of 10^7 and 10^9 CFU/ml respectively for 24 h. To determine the kinetic effect of Pe on OBs, 10^7 CFU/ml of Pe was used to stimulate the cells for 0,6,12,18 and 24 h respectively, RT-PCR were used to examine the RANKL mRNA expression. Results:The grey level ratio of RANKL mRNA expression to β-actin in untreated OBs was 0.32, that in the cells infected by 10^7 and 10^9 CFU/ml of Pe for 24 h was increased to 1.73 and 2.24 respectively. Infected by 107 CFU/nll of Pe for 6,12 and 18 h,the ratio was 0.93,2.01 and 1.97 respectively. Conclusion:Pe may stimulate RANKL expresson in osteoblasts.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2005年第5期583-586,共4页 Journal of Practical Stomatology
关键词 牙髓卟啉单胞菌 成骨细胞 细胞核因子kB受体活化因子配基 Porphyromonas endodonalis Osteoblasts Receptor activator of nuclear factor-kB ligand
  • 相关文献

参考文献10

  • 1Lacey DL, Timms E,Tan HL,et al.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.Cell,1998,93(2):165
  • 2Simonet WS,Lacey DL, Dunstan CR, et al.Osteoprotegerin:A novel secreted protein involved in the regulation of bone density.Cell,1997,89(2):309
  • 3Yasuda H, Shima N,Nakagawa N,et al.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL.Proc Natl Acad Sci USA,1998,95(7):3597
  • 4Wong BR, Rho J, Arron J,et al.TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase In T Cells.J Biol Chem,1997,272(4):25190
  • 5Anderson DM, Maraskovsky E, Billingsley WL,et al.A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.Nature,1997,390(6656):175
  • 6张晓磊,彭彬.TNF配体家族的新成员——RANKL的研究进展[J].国外医学(口腔医学分册),2004,31(3):179-180. 被引量:1
  • 7于世凤,李斌斌.骨保护因子及其配体调控骨吸收的研究进展[J].国外医学(口腔医学分册),2004,31(4):249-252. 被引量:3
  • 8Palmqvist P,Persson E,Conaway HH, et al. IL-1,leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand,osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol,2002,169(6):3353
  • 9Jiang Y,Schilder H. An optimal host response to a bacterium may require the interaction of leukocytes and resident host cells. J Endod,2002,28 (4):279
  • 10Nukaga J,Kobayashi M,Shinki T,et al.Regulatory effects of interleukin-1β and prostaglandin E2 on expression of receptor activator of nuclear factor -kb ligand in human periodontal ligament cells.J Periodontol,2004,75(2): 249

二级参考文献34

  • 1Roodman GD. Endocr Rev, 1995, 17 (4): 308-332.
  • 2Takahashi N, Akatsu T, Udagawa N, et al. Endocrinology,1988, 123 (5) :2600-2602.
  • 3Simonet WS, Lacey DL, Dunstsn CR, et al. Cell, 1997,89 (2) : 309-319.
  • 4Tan KB, Harrop J, Reddy M, et al. Gene, 1997, 204 (1-2) :35-46.
  • 5Yasuda H, Shima N, Nakagawa N, et al. Endocrinology,1998, 139 (3) : 1329-1337.
  • 6Lacey DL, Timms E, Tan HI., et al. Cell, 1998, 93 (2):165-176.
  • 7Anderson MA, Maraskovsky E, Billingsley WL, et al. Nature, 1997, 310 (6656) : 175-179.
  • 8Hoibauer LC, Gori F, Riggs BL. Endocrinology, 1999,140 (10) :4382-4389.
  • 9Hoibauer LC, Khosla S, Dunstan CR, et al. Endocrinology, 1999, 140(9):4367-4370.
  • 10Srivastava S, Torn/do G, Weitzmann MN, et al. J Biol Chem, 2001, 276 (12) : 8836-8840.

共引文献2

同被引文献10

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部